Compounded tirzepatide vs Ozempic

Compare Compounded tirzepatide and Ozempic on active ingredient, dosing schedule, FDA-approved use and pharmacy acquisition cost.

By Sam Reed · Founder and data leadVerified Aug 12, 2026

Compounded tirzepatide

Compounded — no single manufacturer

Active ingredient: Tirzepatide
Form: —
FDA-approved for: Not an FDA-approved product

Not NADAC-indexed

lowest package, pharmacy acquisition cost

Ozempic

Novo Nordisk

Active ingredient: Semaglutide
Form: INJECTION, SOLUTION, TABLET
FDA-approved for: Type 2 diabetes, Cardiovascular risk reduction

$992

lowest package, pharmacy acquisition cost

The short answer

Compounded tirzepatide contains Tirzepatide and Ozempic contains Semaglutide. These are different molecules, so their dosing and clinical evidence differ.

Side by side

Costs are what a pharmacy pays to acquire each product, from CMS NADAC. Not a retail price, and not what you would pay.

Compounded tirzepatide

Ozempic

Lowest package cost

Not NADAC-indexed

$992

Active ingredient

Tirzepatide

Semaglutide

Manufacturer

Compounded

Novo Nordisk

Form

—

INJECTION, SOLUTION, TABLET

FDA-approved for

Not FDA-approved

Type 2 diabetes, Cardiovascular risk reduction

= better value on that rowScroll sideways on small screens — the first column stays pinned

Keep comparing

Byetta vs Compounded tirzepatide Byetta vs Ozempic Compounded liraglutide vs Ozempic Compounded semaglutide vs Ozempic

Data sources · cited with retrieval dates

CMS NADACNational Average Drug Acquisition Cost, weekly fileretrieved Aug 12, 2026
CMS Medicare Part DPrescriber public use file, by geography and drugretrieved Aug 12, 2026
CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement dataretrieved Aug 12, 2026

NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.